Status:
RECRUITING
Video Education With Result Dependent dIsclosure
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
National Human Genome Research Institute (NHGRI)
Conditions:
Genetic Testing
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI) model, increasingly ...
Detailed Description
This study consists of two parts: * Qualitative assessment: * This part of the research study involves watching a brief educational video about genetic testing for inherited cancer risk (about 8 m...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Current or prior diagnosis of breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, renal cancer, melanoma, or sarcoma
- Ability to understand spoken or written English or Spanish in a healthcare context
- Ability to understand and the willingness to sign a written informed consent document
- Black or Latinx (qualitative assessment study only)
Exclusion
- Prior cancer genetic testing
- Prior germline genetic testing
- Active hematologic malignancy (e.g. chronic lymphocytic leukemia)
- Currently pregnant
- Currently incarcerated
Key Trial Info
Start Date :
August 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
1020 Patients enrolled
Trial Details
Trial ID
NCT05225428
Start Date
August 4 2022
End Date
September 1 2026
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115